A next-generation sequencing (NGS) approach ofCDKN1C in children with SRS (n=8), IUGR/FGR (n=37), products of conception (n=22), and mothers with a history of recurrent miscarriage (n=78) also did not reveal pathogenic variants in this PCNA-binding domain region (Table 1). This evidence concerns the gene PCNA and fetal growth restriction.